Form 4 for MMSI MERIT MEDICAL SYSTEMS INC
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-27 · accession 0001415889-25-006307 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-03 | 2025-02-28 | MMSI | Voigt Michel James | CHRO | S - Sale+OE | $99.68 | -13.8K | 22.4K | -38% | -$1.38M |
| DM | 2025-03-03 | 2025-02-28 | MMSI | Voigt Michel James | CHRO | M - OptEx | $61.42 | +13.8K | 36.2K | +62% | +$848.1K |
| D | 2025-03-03 | 2025-02-27 | MMSI | Voigt Michel James | CHRO | F - Tax | $98.50 | -4,530 | 16.9K | -21% | -$446.2K |
| DM | 2025-03-03 | 2025-02-27+ | MMSI | Voigt Michel James | CHRO | A - Grant | $0.00 | +17.0K | 22.4K | +316% | $0 |
| DM | 2025-03-03 | 2025-02-28 | MMSI | Voigt Michel James | CHRO | M - OptEx | $0.00 | -13.8K | 11.1K | -55% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, No Par Value | 2025-02-28 | S | D | 13,809 | $99.68 | 22,399 | D | — | — | (F5) The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.425 to $100.485, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| 2 | Common | Common Stock, No Par Value | 2025-02-28 | M | A | 7,261 | $56.25 | 29,660 | D | — | — | |
| 3 | Common | Common Stock, No Par Value | 2025-02-28 | M | A | 4,048 | $65.03 | 33,708 | D | — | — | |
| 4 | Common | Common Stock, No Par Value | 2025-02-28 | M | A | 2,500 | $70.58 | 36,208 | D | — | — | |
| 5 | Common | Common Stock, No Par Value | 2025-02-27 | F | D | 4,530 | $98.50 | 16,911 | D | — | — | (F3) The Reporting Person surrendered 4,530 shares of common stock to the Issuer for payroll taxes. No shares were sold in the open market. |
| 6 | Common | Common Stock, No Par Value | 2025-02-27 | A | A | 11,533 | $0.00 | 21,441 | D | — | — | (F2) These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02.28.2022. |
| 7 | Common | Common Stock, No Par Value | 2025-02-28 | A | A | 5,488 | $0.00 | 22,399 | D | — | — | (F4) Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting. |
| 8 | Derivative | Non-qualified stock options (right to buy) | 2025-02-28 | M | D | 4,048 | $0.00 | 4,046 | D | $65.03 · 2023-02-28 to 2029-02-28 | 8,094 Common Stock | (F7) Becomes exercisable in equal annual installments of 25% commencing 02/28/2023. |
| 9 | Derivative | Non-qualified stock options (right to buy) | 2025-02-28 | M | D | 7,261 | $0.00 | 2,420 | D | $56.25 · 2022-03-19 to 2028-03-19 | 9,681 Common Stock | (F6) Become exercisable in equal annual installments of 25% commencing on 03/19/2022. |
| 10 | Derivative | Non-qualified stock options (right to buy) | 2025-02-28 | M | D | 2,500 | $0.00 | 11,076 | D | $70.58 · 2024-02-28 to 2030-02-28 | 13,576 Common Stock | (F8) Become exercisable in equal annual installments of 25% commencing on 02/28/2024. |